Parameter | IgM aCL+ | IgM aCL- | P | IgG aCL+ | IgG aCL- | P | Lac+ | Lac- | P |
---|---|---|---|---|---|---|---|---|---|
Number of patients | 9 | 9 | - | 9 | 9 | - | 13 | 5 | - |
Age (years) | 36.4 ± 13.4 | 31.6 ± 6.4 | 0.67 | 31.3 ± 6.5 | 36.7 ± 13.2 | 0.49 | 34.9 ± 10.9 | 31.6 ± 10.2 | 0.50 |
Duration of SLE (years) | 7.4 ± 5.0 | 10.6 ± 8.8 | 0.55 | 8.4 ± 3.6 | 9.6 ± 9.8 | 0.67 | 8.8 ± 7.1 | 9.6 ± 8.0 | 0.85 |
Duration of NPSLE (years) | 4.4 ± 4.0 | 6.2 ± 5.5 | 0.49 | 4.9 ± 3.2 | 5.7 ± 6.1 | 0.73 | 5.7 ± 5.2 | 4.3 ± 3.7 | 0.57 |
Grey matter peak location | 33.8 ± 0.7 | 34.7 ± 1.0 | 0.077 | 34.1 ± 0.3 | 34.3 ± 1.3 | 0.67 | 34.0 ± 0.1 | 34.8 ± 1.3 | 0.34 |
Grey matter peak height | 131 ± 24 | 138 ± 19 | 0.67 | 135 ± 28 | 133 ± 14 | 0.93 | 133 ± 22 | 138 ± 23 | 0.63 |
Grey matter mean MTR | 32.6 ± 0.9 | 33.8 ± 1.0 | 0.011 | 33.0 ± 0.8 | 33.3 ± 1.4 | 0.49 | 32.9 ± 1.1 | 33.8 ± 1.1 | 0.12 |
White matter peak location | 37.2 ± 1.0 | 38.4 ± 1.0 | 0.019 | 37.8 ± 0.4 | 37.9 ± 1.6 | 0.93 | 37.6 ± 1.0 | 38.4 ± 1.6 | 0.50 |
White matter peak height | 184 ± 31 | 178 ± 20 | 0.26 | 185 ± 32 | 177 ± 18 | 0.16 | 180 ± 27 | 183 ± 24 | 0.99 |
White matter mean MTR | 37.2 ± 0.9 | 38.2 ± 1.0 | 0.014 | 37.6 ± 0.3 | 37.8 ± 1.5 | 0.44 | 37.4 ± 0.9 | 38.4 ± 1.3 | 0.14 |